The Facts:
- ZoomInfo’s stock declined sharply, falling from the high $60s in early 2022 to around $8 by April 2024 — a loss of $22 billion in market cap.
- The company made multiple acquisitions (RingLead, Comparably), yet failed to integrate them meaningfully into the product, leaving value on the table.
-Since 2022, ZoomInfo has seen five CMOs come and go, including an experienced and well-liked CMO being let go out of the blue in 2024. The current CMO has limited senior marketing experience but has been with the company a long time, signaling a preference for internal loyalty over fresh perspective.
-The C-suite has seen near-total turnover in the past few years, with new executives stepping away from the CFO and CPO roles in the last 12 months . That level of churn is difficult for any company to absorb.
-ZoomInfo wrote off nearly $130 million in bad debt — a sign that short-term sales pressure led to deals that never should’ve happened.
-In an era dominated by PLG, the buying experience still requires multiple conversations with sales — a friction-heavy process that doesn’t align with modern buyer expectations.
-The product marketing team saw significant voluntary attrition in early 2025. Nearly the whole team has left, and the head of Product Marketing, there for just over a year, was let go unexpectedly despite having a clear vision.
- Revenue declined by $25 million year-over-year, a surprising shift for a company still positioning itself as a growth leader.
On the legal side:
-An active investor class-action lawsuit is underway, focused on whether the board overstated performance and failed to disclose customer churn risks.
-ZoomInfo has paid over $29 million in settlements related to privacy and data collection concerns.
-Employee benefits have grown more expensive while offering less each year.
-The return-to-office policy has changed multiple times, creating confusion and frustration. A one-size-fits-all approach makes it harder to retain experienced professionals who thrive in more flexible environments.